Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing

Active
HT942626RE023Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to research and development focused on vector-borne disease agent surveillance through external proficiency testing. It is a combined synopsis-solicitation incorporating the performance work statement and quality assurance surveillance plan, issued by the Defense Health Agency under the Department of Defense. The solicitation number is HT942626RE023, and it was posted on June 9, 2026, with responses due by June 29, 2026, at 2:00 PM. This opportunity is classified under NAICS code 541714 and involves no set-aside designation. The work will be performed within Maryland, with administrative offices based in Fort Detrick, MD. The contract targets the provision of specialized research services to enhance surveillance capabilities related to vector-borne diseases, critical for defense health initiatives. Points of contact for this solicitation include Benjamin Marcus and Erin Maddox, who are available for inquiries. The solicitation details, including the combined synopsis and associated documents, are accessible through the official government contract portal. The project emphasizes quality assurance and monitoring to ensure compliance and performance standards.

General Info

Research contract for vector-borne disease surveillance via proficiency testing, Defense Health Agency, Maryland.

Agency

Department Of Defense → Defense Health Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

(5)

Combined Synopsis/Solicitation HT942626RE023 for Vector-borne Disease Surveillance R&D

PDFrfq

Pacific Region Force Health Protection Vector-borne Disease Agent Surveillance PWS

DOCXpws

Combined+Synopsis+Solicitation+-+HT942626RE0230001.pdf

PDF

QASP for Pacific Region Force Health Protection Vector-borne Disease Agent Surveillance

DOCXqasp

Solicitation+Amendment+HT942626RE0230001+SF+30.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseCombined Synopsis
Posted

Combined Synopsis

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeFORT DETRICK, MD, 21702, USA
Organization / Agency
Department Of Defense → Defense Health Agency
Office AddressFORT DETRICK, MD, 21702, USA
Contacts
Benjamin Marcus

Full Description

Show more

Please see the attached combined synopsis-solicitation, performance work statement (PWS), and quality assurance surveillence plan (QASP). 


Amendment 0001 includes one administrative chnage and contractor Q&A.


Similar Contracts

NAICS: 541714
New
Federal
PAXGENE Ribonucleic acid extraction, quality control and aliquoting services​This contract is focused on procuring specialized laboratory services to support the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) clinical research activities. Specifically, it requires the extraction, quantitation, normalization, quality control, aliquoting, frozen storage, and shipment of ribonucleic acid (RNA) from 122 PAXgene tubes collected from 50 clinical participants. The services are essential for advancing gene expression profiling, molecular characterization of biospecimens, and subsequent transcriptomic analyses aimed at understanding disease mechanisms and therapeutic targets. The contractor must adhere to rigorous quality control standards, including performing DNase treatment to remove DNA contaminants, ensuring RNA integrity via Agilent instrumentation, and maintaining secure frozen storage conditions. They are also responsible for complete documentation and traceability throughout the processing stages and must notify NIDDK promptly if any specimen is compromised upon receipt. Additionally, the contractor will provide certificates of analysis, donor documentation, shipment records, and maintain the cold chain during storage and shipment. Regular communication with NIDDK personnel regarding order status and shipment tracking is also required to ensure smooth project execution. The contract is managed under the Department of Health and Human Services and will be performed in Maryland.
National Institutes Of Health Olao

POSTED

2 days ago

DEADLINE

in 9 days
View Details